Litcius/Paper detail

Newly approved cancer drugs in China — innovation and clinical benefit

Yichen Zhang, Anita K. Wagner, Xiaodong Guan

2023Nature Reviews Clinical Oncology21 citationsDOI

Topics & Concepts

MedicineCancer drugsCancerChinaMechanism (biology)Intensive care medicinePharmacologyOncologyInternal medicinePolitical scienceEpistemologyPhilosophyLawAdvanced Breast Cancer TherapiesCancer Genomics and DiagnosticsEconomic and Financial Impacts of Cancer
Newly approved cancer drugs in China — innovation and clinical benefit | Litcius